Approach to cost-effectiveness assessment in the MADIT trial

American Journal of Cardiology

Volumn 80, Issue 5 B, 1997, Pages

  Mushlin, Alvin I ^a   Zwanziger, Jack ^a   Gajary, Elizabeth ^a   Andrews, Mark ^a   Marron, Rebecca ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FEMALE; HEALTH CARE FINANCING; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; SUDDEN DEATH;

EID: 0030793801     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00476-1     Document Type: Conference Paper

References (19)

1. Kupperman M, Luce BR, McGovern B, Podrid PJ, Bigger T Jr, Ruskin JN. An analysis of the cost effectiveness of the ICD. Circulation. 81:1990;91-100.
2. Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NAM, Pauker SG. Cost effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol. 19:1992;1323-1334.
3. Kuppersmith J, Hogan A, Guerrero P, Gardiner J, Mellits ED, Baumgarder R, Rovner D, Holmes-Rovner M, McLane A, Levine J, Saksena S, Griffith L. Evaluating and improving the cost effectiveness of the implantable cardioverter-defibrillator. Am Heart J. 130:1995;507-515.
4. Wever EFD, Hauer RNW, Schrijvers G, van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Ramanna H, Bakker PFA, de Medina EOR. Cost effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: a randomized study. Circulation. 93:1996;489-496.
5. O'Donoghue S, Platia EV. Brooks-Robinson S, Mispireta L. ICD: is early implantation cost effective. J Am Coll Cardiol. 16:1990;1258-1263.
6. Anderson MH, Camm AJ. Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy. Br Heart J. 69:1993;83-92.
7. O'Brien BJ, Buxton MJ, Rushby JA. Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis. Br Heart J. 68:1992;241-245.
8. Owens DK, Sanders GD, Harris RA, McKonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 126:((1)):1997;1-12.
9. Valenti R, Schlapfer J, Fromer M, Fischer A, Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart. 17:1996;1565-1571.
10. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN. Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 318:1988;19-24.
11. Wilber DJ, Olshansky B, Moran JR, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation. 82:1990;350-358.
12. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 13:1988;1353-1361.
13. Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM. Long-term results of amiodarone therapy with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol. 13:1989;442-449.
14. Levine JH, Mellitis ED, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LS. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter defibrillators. Circulation. 84:1991;558-566.
15. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. for the MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
16. Mitchell JB. Private communication. 1995.
17. Federal Register Part II. Medicare Program; Physician Fee Schedule for Calendar Year 1995; Payment Policies and Relative Value Unit Adjustments; Final Rule Department of Health and Human Services.
18. Physician's Desk Reference. 1992, 1993, 1994, 1995, 1996 Editions. Montvale, NJ: Medical Economics Company.
19. 1995 Drug Topics Red Book. Montvale, NJ: Medical Economics Data Company.